FindTrial
Sign In

Intraoperative cell salvage in high bleeding risk cesarean section: A prospective randomized controlled multi-center clinical trial

Intraoperative cell salvage in high bleeding risk cesarean section: A prospective randomized controlled multi-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICC-15007096
Enrollment
Unknown
Registered
2015-09-18
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high bleeding risk cesarean section

Interventions

ICS group:intraoperative cell salvage
ABT group:Allogeneic blood transfusion

Sponsors

Department of Anesthesiology of the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. >=18 years; 2. caesarean section; 3. ASA physical status classification I~II; 4. expected blood loss>=1000ml.

Exclusion criteria

Exclusion criteria: 1. Preoperative Hb 1.5 times normal value; 4. With hematological diseases; 5. Preoperative anticoagulant therapy; 6. Weight < 45kg; 7. Wiith autoimmune disease / acute fatty liver /HELLP syndrome; 8. Received allogeneic blood transfusion in 3 months before the study; 9. Refuse allogeneic blood transfusion; 10. Participated in other clinical research during pregnancy; 11. Any cause that can not comply with the study including mental illness, etc.

Design outcomes

Primary

MeasureTime frame
volume of allogeneic blood transfusion;morbidity andmortality;—

Secondary

MeasureTime frame
hemoglobin;coagulation function;postoperative delirium;ICU stay;hospital stay andcost;—

Countries

China

Contacts

Public ContactZhang Wei
zhangw571012@126.com+86 13673996966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026